Curik, Nikola
Laznicka, Adam
Polivkova, Vaclava
Krizkova, Jitka
Pokorna, Eva
Semerak, Pavel
Suchankova, Pavla
Burda, Pavel http://orcid.org/0000-0002-2841-792X
Hochhaus, Andreas
Machova Polakova, Katerina http://orcid.org/0000-0002-7398-5555
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (00023736)
Grantová Agentura, Univerzita Karlova (492222)
European Treatment and Outcome for CML 2022
Article History
Received: 23 February 2024
Revised: 3 April 2024
Accepted: 5 April 2024
First Online: 13 April 2024
Competing interests
: KMP and AH received support by Novartis through the European Treatment and Outcome Study (EUTOS) for CML.